A Qualitative Progression in HIV Type 1 Glycoprotein 120-Specific Cytotoxic Cellular and Humoral Immune Responses in Mice Receiving a DNA-Based Glycoprotein 120 Vaccine-Reference-Cited by-同舟云学术

A Qualitative Progression in HIV Type 1 Glycoprotein 120-Specific Cytotoxic Cellular and Humoral Immune Responses in Mice Receiving a DNA-Based Glycoprotein 120 Vaccine

Published:1994-11 Issue:11 Volume:10 Page:1433-1441
ISSN:0889-2229
Container-title:AIDS Research and Human Retroviruses
language:en
Short-container-title:AIDS Research and Human Retroviruses

Author:

FULLER DEBORAH HEYDENBURG,HAYNES JOEL R.

Publisher

Mary Ann Liebert Inc

Subject

Infectious Diseases,Virology,Immunology

Link

http://www.liebertpub.com/doi/pdf/10.1089/aid.1994.10.1433

Reference45 articles.

1. Detection of Anti-Human Cell Antibodies in Sera from Macaques Immunized with Whole Inactivated Virus

2. The Ability of Certain SIV Vaccines to Provoke Reactions Against Normal Cells

3. Studies on the Specificity of the Vaccine Effect Elicited by Inactivated Simian Immunodeficiency Virus

4. Protection of Macaques Against SIV Infection by Subunit Vaccines of SIV Envelope Glycoprotein gp160

5. Vaccine Protection of Chimpanzees Against Challenge with HIV-1-Infected Peripheral Blood Mononuclear Cells

Cited by 129 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nucleic Acid Vaccines;Journal of Preventive, Diagnostic and Treatment Strategies in Medicine;2022-10

2. STING Is Required in Conventional Dendritic Cells for DNA Vaccine Induction of Type I T Helper Cell- Dependent Antibody Responses;Frontiers in Immunology;2022-04-22

3. A Guide to Nucleic Acid Vaccines in the Prevention and Treatment of Infectious Diseases and Cancers: From Basic Principles to Current Applications;Frontiers in Cell and Developmental Biology;2021-05-25

4. A DNA inducing VLP vaccine designed for HIV and tested in mice;PLOS ONE;2017-08-24

5. Advancements in DNA vaccine vectors, non-mechanical delivery methods, and molecular adjuvants to increase immunogenicity;Human Vaccines & Immunotherapeutics;2017-06-12